ガラス固化市場- 世界の産業規模、シェア、動向、機会、予測、検体別（卵子、胚、精子）、最終用途別、地域別、競合別、2020-2030F

ガラス固化の世界市場規模は2024年に95億3,000万米ドルとなり、2030年には221億2,000万米ドルに達すると予測され、予測期間中に15.04%の年間平均成長率（CAGR）を記録すると予測されています。

ガラス固化は先進的な冷凍保存技術であり、医療、バイオテクノロジーから環境保全に至るまで、様々な業界で大きな支持を得ています。このプロセスでは、液体を結晶化させることなくガラスのような固体に変化させます。凍結保存において、ガラス固化は細胞、組織、胚などの生物学的サンプルを超低温（通常-196℃または-321°F）で保存するのに特に効果的です。従来の凍結方法とは異なり、ガラス固化は氷晶の形成を排除するため、細胞へのダメージを最小限に抑え、解凍後の生存率を高めます。

生殖補助医療（ART）分野は、市場成長の主要な促進要因です。ガラス固化は卵子や胚の保存に革命をもたらし、体外受精（IVF）の成功率を大幅に向上させました。また、この技術は幹細胞バンクや再生医療においても重要な役割を果たしており、先端治療や創薬に使用する多能性幹細胞の長期保存を容易にしています。さらに、バイオバンクでの採用も増えており、臨床研究に不可欠な生物学的標本の安全な長期保存を可能にしています。

新たなアプリケーションとしては、臓器保存があり、ガラス固化はドナー臓器の生存期間を延長し、移植の成果を高める可能性を秘めています。さらに、環境保全の分野では、絶滅危惧種の遺伝物質を保存し、種子の凍結保存を通じて植物の生物多様性を保護するために、この技術が活用されています。

主な市場促進要因

バイオバンキングと組織工学の成長

主な市場課題

ガラス固化技術の高コスト

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のガラス固化市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 標本別（卵母細胞（機器、キット、消耗品）、胚（機器、キット、消耗品）、精子）
  • 最終用途別（体外受精クリニック、バイオバンク）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のガラス固化市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のガラス固化市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のガラス固化市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のガラス固化市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのガラス固化市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品開発
• 最近の動向

第13章 世界のガラス固化市場：SWOT分析

第14章 競合情勢

• Vitrolife Inc.
• Genea Biomedx inc.
• NidaCon International AB
• Minitube International
• IMV Technologies Group（Cryo Bio System）
• The Cooper Companies, Inc.（A CooperSurgical Fertility Company）
• FUJIFILM Corporation（FUJIFILM Irvine Scientific）
• Biotech, Inc.
• Kitazato Corporation
• Shenzhen VitaVitro BiotechAGEN N.V.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Vitrification Market was valued at USD 9.53 billion in 2024 and is projected to reach USD 22.12 billion by 2030, registering a compound annual growth rate (CAGR) of 15.04% during the forecast period.

Vitrification, an advanced cryopreservation technique, has gained significant traction across multiple industries, ranging from medicine and biotechnology to environmental conservation. This process involves the transformation of a liquid into a solid glass-like state without crystallization. In cryopreservation, vitrification is particularly effective for preserving biological samples-such as cells, tissues, and embryos-at ultra-low temperatures (typically -196°C or -321°F). Unlike conventional freezing methods, vitrification eliminates the formation of ice crystals, thereby minimizing cellular damage and enhancing post-thaw viability.

The Assisted Reproductive Technology (ART) sector is a primary driver of market growth. Vitrification has revolutionized oocyte and embryo preservation, substantially improving success rates in in vitro fertilization (IVF) procedures. The technique also plays a vital role in stem cell banking and regenerative medicine, facilitating the long-term storage of pluripotent stem cells for use in advanced therapies and drug discovery. Additionally, vitrification is increasingly adopted in biobanking, where it enables the secure, long-term storage of biological specimens critical for clinical research.

Emerging applications include organ preservation, where vitrification holds the potential to extend the viability of donor organs and enhance transplant outcomes. Moreover, in environmental conservation, the technology is being utilized to preserve genetic material from endangered species and to safeguard plant biodiversity through seed cryopreservation.

Key Market Drivers

Growth in Biobanking and Tissue Engineering

The rapid expansion of biobanking and tissue engineering has become a major catalyst for the global vitrification market. Vitrification's ability to preserve biological specimens in a glass-like state at ultra-low temperatures is essential for ensuring the long-term integrity of samples used in both research and clinical settings.

Biobanks, which store a wide range of biological materials-such as DNA, tissues, and cells-play a crucial role in medical research and therapeutic development. According to the World Health Organization (WHO), over 120 biobanks globally held more than 20 million biological samples as of 2023. The increasing demand for reliable preservation methods has positioned vitrification as a preferred technique due to its superior ability to maintain cellular structure and viability over extended periods.

Key Market Challenges

High Cost of Vitrification Technology

Despite its advantages, the high cost associated with vitrification technology presents a significant barrier to market expansion. The process requires advanced equipment, specialized cryoprotectants, and highly skilled personnel, all of which contribute to elevated capital and operational expenditures.

Establishing a vitrification facility necessitates investment in programmable freezers, cryogenic storage systems, and other high-grade materials. Additionally, continuous maintenance-including liquid nitrogen supply, regulatory compliance, and equipment calibration-further inflates operational costs.

Labor costs are also considerable, as embryologists and laboratory technicians must undergo extensive training to handle sensitive biological materials with precision. Any deviation from protocol can compromise the viability of preserved samples, emphasizing the need for highly qualified professionals.

In developing countries or regions with constrained healthcare budgets, the cost of implementing vitrification technologies can be prohibitive. This limits geographic expansion and restricts access to fertility preservation services for lower-income populations-particularly patients undergoing cancer treatment or gender-affirming care.

Moreover, insurance coverage for fertility preservation is often limited or unavailable, placing the financial burden on patients. The high out-of-pocket expenses discourage many from pursuing vitrification, especially when multiple treatment cycles are required. These economic limitations hinder the widespread adoption of vitrification technologies and raise broader concerns about equitable access to advanced reproductive healthcare.

Key Market Trends

Advancements in Technology

Technological innovation continues to reshape the vitrification landscape, particularly in cryopreservation. Traditional freezing methods often resulted in ice crystal formation, leading to cellular damage. New vitrification techniques eliminate this risk, enabling safer and more effective preservation of cells, tissues, and even entire organs. This progress has significant implications for organ transplantation, IVF, and stem cell therapies.

In materials science, the development of enhanced glass-forming substances with improved resistance to thermal shock and greater transparency is facilitating broader application of vitrification in optics, where precision components such as lenses and prisms require high-quality materials.

The pharmaceutical and biotechnology sectors are also embracing vitrification to develop stable and long-lasting formulations for biopharmaceuticals and vaccines. These methods ensure the preservation of drug efficacy during storage and transport-particularly valuable in resource-limited settings.

In the electronics industry, vitrification is being applied to the production of high-performance devices. Technologies like amorphous silicon and other vitrified materials are central to the manufacture of thin-film transistors and liquid crystal displays (LCDs), contributing to more efficient, lightweight, and visually superior electronic products.

These diverse advancements are expanding the scope of vitrification well beyond traditional biological preservation, positioning it as a transformative technology across multiple high-growth industries.

Key Market Players

• Vitrolife Inc.
• Genea Biomedx inc.
• NidaCon International AB
• Minitube International
• IMV Technologies Group (Cryo Bio System)
• The Cooper Companies, Inc. (A CooperSurgical Fertility Company)
• FUJIFILM Corporation (FUJIFILM Irvine Scientific)
• Biotech, Inc.
• Kitazato Corporation
• Shenzhen VitaVitro BiotechAGEN N.V.

Report Scope:

In this report, the Global Vitrification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitrification Market, By Specimen:

• Oocytes
• Embryo
• Sperm

Vitrification Market, By End-use:

• IVF Clinics
• Biobanks

Vitrification Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitrification Market.

Available Customizations:

Global Vitrification market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Vitrification Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Specimen (Oocytes (Devices, Kits & Consumables) ,Embryo (Devices, Kits & Consumables), Sperm)
  • 5.2.2. By End-use (IVF Clinics, Biobanks)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Vitrification Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Specimen
  • 6.2.2. By End-use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vitrification Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Specimen
      • 6.3.1.2.2. By End-use
  • 6.3.2. Canada Vitrification Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Specimen
      • 6.3.2.2.2. By End-use
  • 6.3.3. Mexico Vitrification Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Specimen
      • 6.3.3.2.2. By End-use

7. Europe Vitrification Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Specimen
  • 7.2.2. By End-use
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vitrification Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Specimen
      • 7.3.1.2.2. By End-use
  • 7.3.2. United Kingdom Vitrification Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Specimen
  • 7.3.3. Italy Vitrification Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Specimen
      • 7.3.3.2.2. By End-use
  • 7.3.4. France Vitrification Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Specimen
      • 7.3.4.2.2. By End-use
  • 7.3.5. Spain Vitrification Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Specimen
      • 7.3.5.2.2. By End-use

8. Asia-Pacific Vitrification Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Specimen
  • 8.2.2. By End-use
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vitrification Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Specimen
      • 8.3.1.2.2. By End-use
  • 8.3.2. India Vitrification Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Specimen
      • 8.3.2.2.2. By End-use
  • 8.3.3. Japan Vitrification Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Specimen
      • 8.3.3.2.2. By End-use
  • 8.3.4. South Korea Vitrification Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Specimen
      • 8.3.4.2.2. By End-use
  • 8.3.5. Australia Vitrification Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Specimen
      • 8.3.5.2.2. By End-use

9. South America Vitrification Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Specimen
  • 9.2.2. By End-use
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vitrification Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Specimen
      • 9.3.1.2.2. By End-use
  • 9.3.2. Argentina Vitrification Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Specimen
      • 9.3.2.2.2. By End-use
  • 9.3.3. Colombia Vitrification Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Specimen
      • 9.3.3.2.2. By End-use

10. Middle East and Africa Vitrification Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Specimen
  • 10.2.2. By End-use
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vitrification Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Specimen
      • 10.3.1.2.2. By End-use
  • 10.3.2. Saudi Arabia Vitrification Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Specimen
      • 10.3.2.2.2. By End-use
  • 10.3.3. UAE Vitrification Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Specimen
      • 10.3.3.2.2. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Vitrification Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Vitrolife Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Genea Biomedx inc.
• 14.3. NidaCon International AB
• 14.4. Minitube International
• 14.5. IMV Technologies Group (Cryo Bio System)
• 14.6. The Cooper Companies, Inc. (A CooperSurgical Fertility Company)
• 14.7. FUJIFILM Corporation (FUJIFILM Irvine Scientific)
• 14.8. Biotech, Inc.
• 14.9. Kitazato Corporation
• 14.10. Shenzhen VitaVitro BiotechAGEN N.V.

15. Strategic Recommendations

16. About Us & Disclaimer